North China Pharmaceutical Co Ltd (600812) — Long-term Investment Intensity
North China Pharmaceutical Co Ltd (600812) has a Long-term Investment Intensity of 3.7% as of September 2019. Long-term investments of CN¥691.12 Million represent 3.7% of total assets of CN¥18.46 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See what is North China Pharmaceutical Co Ltd's book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
North China Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how North China Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 3.7%, reflecting long-term investments of CN¥691.12 Million against total assets of CN¥18.46 Billion CNY. Also explore 600812 total asset value for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for North China Pharmaceutical Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for North China Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 600812 market cap overview.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 3.8% | CN¥677.26 Million | CN¥17.92 Billion | ▼ -0.1 pp |
| 2017 | 3.9% | CN¥670.92 Million | CN¥17.15 Billion | ▲ +1.3 pp |
| 2016 | 2.6% | CN¥433.59 Million | CN¥16.48 Billion | ▲ +0.1 pp |
| 2015 | 2.5% | CN¥403.28 Million | CN¥16.00 Billion | — |